John R. Asplin

9.0k total citations · 2 hit papers
164 papers, 6.3k citations indexed

About

John R. Asplin is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John R. Asplin has authored 164 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Pulmonary and Respiratory Medicine, 55 papers in Nephrology and 49 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John R. Asplin's work include Kidney Stones and Urolithiasis Treatments (136 papers), Pediatric Urology and Nephrology Studies (48 papers) and Therapeutic Uses of Natural Elements (28 papers). John R. Asplin is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (136 papers), Pediatric Urology and Nephrology Studies (48 papers) and Therapeutic Uses of Natural Elements (28 papers). John R. Asplin collaborates with scholars based in United States, Canada and Germany. John R. Asplin's co-authors include Fredric L. Coe, Joan H. Parks, David S. Goldfarb, David A. Bushinsky, Ignacio Granja, Jeffrey D. Rimer, John R. Hoyer, Sharon M. Moe, Peter S. Aronson and Jihae Chung and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of the American Chemical Society.

In The Last Decade

John R. Asplin

157 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pathogenesis and Treatment of Kidney Stones

1992 544 citations Fredric L. Coe, Joan H. Parks et al. profile →
Effects of Phosphate Binders in Moderate CKD

2012 377 citations John R. Asplin, Myles Wolf et al. profile →

Peers

Countries citing papers authored by John R. Asplin

Since Specialization

Citations

This map shows the geographic impact of John R. Asplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Asplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Asplin more than expected).

Fields of papers citing papers by John R. Asplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Asplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Asplin. The network helps show where John R. Asplin may publish in the future.

Co-authorship network of co-authors of John R. Asplin

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Asplin. A scholar is included among the top collaborators of John R. Asplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Asplin. John R. Asplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters 2025 ·Kidney360 ·Jennifer A. Schaub, Mary Oerline, Joseph J. Crivelli, Naim M. Maalouf, Sara L. Best, John R. Asplin, John M. Hollingsworth, Vahakn B. Shahinian, Ryan S. Hsi	0
2	Comparison of Thiazide Versus Alkali for Kidney Stone Recurrence Among Individuals With Hypocitraturia and High Urine pH 2025 ·Kidney Medicine ·Ryan S. Hsi, Mary Oerline, Sara L. Best, Joseph J. Crivelli, John R. Asplin, Vahakn B. Shahinian, John M. Hollingsworth	0
3	Beneficial Impact of Follow-Up 24-Hour Urine Testing on Adherence to Pharmacological Therapy for Kidney Stone Prevention 2024 ·JU Open Plus ·(unknown), Joseph J. Crivelli, Phyllis Yan, Ryan S. Hsi, Vahakn B. Shahinian, John R. Asplin, John M. Hollingsworth, Brian T. Denton	0
4	First reported magnesium pyrophosphate kidney stone prompts diagnosis of hypophosphatasia 2024 ·Urology Case Reports ·Carlos E. Araya, (unknown), John R. Asplin, Sara L. Best	1
5	Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones 2023 ·Clinical Journal of the American Society of Nephrology ·Pietro Manuel Ferraro, Eric N. Taylor, John R. Asplin, Gary C. Curhan	0
6	Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats 2019 ·The Nephron journals/Nephron journals ·Nancy S. Krieger, Marc D. Grynpas, (unknown), John R. Asplin, Kevin K. Frick, Min Ho Kim, (unknown), Ignacio Granja, David A. Bushinsky	4
7	Can a Simplified 12-Hour Nighttime Urine Collection Predict Urinary Stone Risk? 2017 ·Urology ·Bryan Hinck, (unknown), (unknown), John R. Asplin, Ignacio Granja, (unknown), Sri Sivalingam, Manoj Monga	6
8	Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes 2016 ·Kidney International ·Julia J. Scialla, John R. Asplin, Mirela Dobre, Alex R. Chang, James P. Lash, Chi‐yuan Hsu, Radhakrishna R. Kallem, L. Lee Hamm, Harold I. Feldman, Jing Chen, Lawrence J. Appel, Cheryl A.M. Anderson, Myles Wolf, Alan S. Go, Jiang He, John W. Kusek, Akinlolu Ojo, Mahboob Rahman, Raymond R. Townsend	41
9	Geographic Variation in the Quality of Secondary Prevention for Nephrolithiasis 2015 ·Urology ·(unknown), Casey A. Dauw, (unknown), John R. Asplin, Khurshid R. Ghani, J. Stuart Wolf, John M. Hollingsworth	8
10	NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy 2013 ·Kidney International ·Felix Knauf, John R. Asplin, Ignacio Granja, Insa M. Schmidt, Gilbert Moeckel, R David, Richard A. Flavell, Peter S. Aronson	178
11	Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease 2010 ·Clinical Journal of the American Society of Nephrology ·Sharon M. Moe, (unknown), Mary Chambers, Lisa Jackman, J. S. Radcliffe, (unknown), (unknown), John R. Asplin	372
12	The Risk of Recurrent Urolithiasis in Children Is Dependent on Urinary Calcium and Citrate 2010 ·Urology ·William DeFoor, Elizabeth Jackson, Eugene Minevich, (unknown), Pramod Reddy, Curtis Sheldon, John R. Asplin	32
13	A Randomized, Controlled Trial of Lactic Acid Bacteria for Idiopathic Hyperoxaluria 2007 ·Clinical Journal of the American Society of Nephrology ·David S. Goldfarb, Frank Modersitzki, John R. Asplin	76
14	Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats 2006 ·Kidney International ·David A. Bushinsky, Kerry L. LaPlante, John R. Asplin	20
15	Urinary cystine excretion and capacity in patients with cystinuria 2006 ·Kidney International ·David S. Goldfarb, Fredric L. Coe, John R. Asplin	59
16	Reduced crystallization inhibition by urine from women with nephrolithiasis 2002 ·Kidney International ·John R. Asplin, Joan H. Parks, (unknown), Fredric L. Coe	58
17	Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals 2001 ·Kidney International ·John R. Hoyer, John R. Asplin, László Ötvös	111
18	Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats 2000 ·Kidney International ·David A. Bushinsky, Walter R. Parker, John R. Asplin	0
19	Isolated hypercalciuria with mutation in CLCN5: Relevance to idiopathic hypercalciuria 2000 ·Kidney International ·Steven J. Scheinman, (unknown), Sarah E. Lloyd, Simon H. S. Pearce, (unknown), R R Hoopes, David A. Bushinsky, Oliver Wrong, John R. Asplin, Craig B. Langman, Anthony G.W. Norden, Rajesh V. Thakker	49
20	Low molecular weight ('tubular') proteinuria in patients with mutations of the CLCN5 renal chloride channel gene. 1999 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·(unknown), John R. Asplin, (unknown), (unknown), (unknown), (unknown), RJ Unwin, O M Wrong	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact